# Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

> **NCT04452084** · PHASE2 · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 42 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** HA-WBRT
- **RADIATION:** HA-SIB-WBRT

## Key facts

- **NCT ID:** NCT04452084
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452084, "Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04452084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*